Home

invade Dew Bluebell kevin harrington icr Laugh Officer worm

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

Get A-Head Visit The Institute of Cancer Research - Get Ahead
Get A-Head Visit The Institute of Cancer Research - Get Ahead

The ICR (@ICR_London) / Twitter
The ICR (@ICR_London) / Twitter

Tumour assassination – using smart targeted treatments to enhance  anti-cancer radiation responses - The Institute of Cancer Research, London
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London

Using imaging to predict and improve responses to immunotherapy - Oracle  Cancer Trust
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust

The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP &  Shadow Health Secretary) to visit us today with @CRUK_Policy to meet  Professor Kevin Harrington and team. Jon saw some of
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of

High-tech radiotherapy, drug combinations and immunotherapy showcased as  future of cancer treatment - The Institute of Cancer Research, London
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London

Professor Kevin Harrington - YouTube
Professor Kevin Harrington - YouTube

Loop | Kevin Joseph Harrington
Loop | Kevin Joseph Harrington

Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The  Institute of Cancer Research, London
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London

SAB and I-O AB - T3 Pharma
SAB and I-O AB - T3 Pharma

Cancer survival 'to double in 10 years' - PressReader
Cancer survival 'to double in 10 years' - PressReader

ICR Discovery Club showcases how we combine therapies to target  hard-to-treat cancers - The Institute of Cancer Research, London
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London

Professor Kevin... - The Institute of Cancer Research | Facebook
Professor Kevin... - The Institute of Cancer Research | Facebook

ICR calls for improved biomarker cancer tests to help personalise treatment  - PMLiVE
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE

The ICR on Twitter: "Professor Kevin Harrington introduces our  world-leading work on #immunotherapy, and how we are finding new ways to  tackle melanomas, head and neck, and other cancers  #partneringtodefeatcancer https://t.co/Q2nRhOW9c7" /
The ICR on Twitter: "Professor Kevin Harrington introduces our world-leading work on #immunotherapy, and how we are finding new ways to tackle melanomas, head and neck, and other cancers #partneringtodefeatcancer https://t.co/Q2nRhOW9c7" /

Science Talk - Immunotherapy goes viral: ICR research on cancer-killing  viruses featured on BBC's The One Show - The Institute of Cancer Research,  London
Science Talk - Immunotherapy goes viral: ICR research on cancer-killing viruses featured on BBC's The One Show - The Institute of Cancer Research, London

ICR Discovery Club showcases how we combine therapies to target  hard-to-treat cancers - The Institute of Cancer Research, London
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London

ICR researchers named among world's most influential scientists - The  Institute of Cancer Research, London
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR +  @royalmarsdenNHS) featured earlier in a @BBCr4today segment on  #immunotherapy. In the UK you can still listen to today's live program
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program

The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will  present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV  expressing an anti-CTLA-4 antibody as a single agent and combined
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined

The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the  @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR  #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter

Connections blog - ICR celebrates innovation and commercialisation at staff  awards - The Institute of Cancer Research, London
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London